PMC:2681008 / 1161-1168 JSON TXT

Loss of the Metalloprotease ADAM9 Leads to Cone-Rod Dystrophy in Humans and Retinal Degeneration in Mice Abstract Cone-rod dystrophy (CRD) is an inherited progressive retinal dystrophy affecting the function of cone and rod photoreceptors. By autozygosity mapping, we identified null mutations in the ADAM metallopeptidase domain 9 (ADAM9) gene in four consanguineous families with recessively inherited early-onset CRD. We also found reduced photoreceptor responses in Adam9 knockout mice, previously reported to be asymptomatic. In 12-month-old knockout mice, photoreceptors appear normal, but the apical processes of the retinal pigment epithelium (RPE) cells are disorganized and contact between photoreceptor outer segments (POSs) and the RPE apical surface is compromised. In 20-month-old mice, there is clear evidence of progressive retinal degeneration with disorganized POS and thinning of the outer nuclear layer (ONL) in addition to the anomaly at the POS-RPE junction. RPE basal deposits and macrophages were also apparent in older mice. These findings therefore not only identify ADAM9 as a CRD gene but also identify a form of pathology wherein retinal disease first manifests at the POS-RPE junction. Main Text Cone-rod dystrophy (CRD [MIM #120970]) is a group of genetically and phenotypically heterogenous retinal disorders usually manifesting in childhood or early adulthood. CRD is characterized by predominant or equal loss of cone compared to rod photoreceptors, reduced visual acuity, color-vision abnormalities, photophobia, and visual-field loss. To date, 11 genes and a further six loci have been associated with CRD, which is most commonly inherited in an autosomal-dominant manner (RetNet). So far, only ABCA41–3 (MIM ∗601691) and RPGRIP14 (MIM +605446) mutations have been shown to cause nonsyndromic autosomal-recessive CRD, with two other published recessive loci.5,6 Only RPGR (MIM ∗312610) mutations have been associated with X-linked CRD.7,8 The CRD locus CORD9 on chromosome 8p11 was first identified in a consanguineous Brazilian family with childhood-onset visual-acuity impairment leading to major loss of central and peripheral vision.5 Haplotype analysis revealed a 12 Mb region with two putative homozygous segments (5 and Figure 1A). To further refine the locus, we used autozygosity mapping, genotyping over 200 microsatellite markers and single-nucleotide polymorphisms (SNPs) within the published locus in two affected individuals (Table S1, available online). Known microsatellite markers and SNPs were selected from the UCSC genome browser or the International HapMap project. Where possible, SNPs with relatively high levels of heterozygosity were chosen. Microsatellites were genotyped on an ABI PRISM 377 DNA Sequencer and analyzed with Genscan 2.0.2 and Geno Typer 1.1.1 software (Applied Biosciences). SNPs were analyzed by direct sequencing. The individuals genotyped were from different sibships and are indicated by arrows in Figure 2. These data provided support for a 2.95 Mb homozygous segment between rs10955025 and rs725401 containing 34 genes (Figures 1B and 1C). Candidate genes were chosen on the basis of known expression in the vertebrate retina or eye, homology or functional similarity to known retinal degeneration genes, published studies indicating potential retinal function, and published interactions with proteins thought to be important for retinal function. We amplified genomic DNA by PCR and sequenced ten genes within this region in affected individuals (Figure 1). Sequencing revealed a homozygous point mutation in the ADAM9 gene (MIM ∗602713), altering the first base of intron 11 (c.1130+1G→A) and abolishing the splice-site (Figure 2A). This mutation was excluded in 190 ethnically matched control individuals by restriction digest with BspHI. Further autozygosity mapping with 10k and 250k Affymetrix SNP arrays and microsatellite markers identified three additional CORD9-linked families of Pakistani (MEP49), Tunisian Jewish (MOL0172), and Arab Muslim (MOL0277) origin. Each was consanguineous and showed a recessive inheritance pattern. Affected individuals in these families reported poor visual acuity in the first decade of life, but nystagmus and photophobia were not noted. Outer retinal atrophy was observed in the macula. Most patients had discrete white patches in the posterior pole and around the optic disc with a pigmentary retinopathy, anterior to the equator. The midperipheral retina showed minimal changes on clinical examination of young patients. In older patients, peripheral pigmentary changes could be observed in some cases. As previously published,5 electroretinograms (ERGs) showed a similar degree of rod and cone involvement. The study of human subjects was performed after all individuals provided informed consent. Approval was obtained from the institutional review boards of the participating centers. Direct sequencing of ADAM9 in MEP49 revealed a homozygous point mutation in exon 9, creating a premature stop codon (c.766C→T; p.R256X) (Figure 2A). A second homozygous stop codon was identified in MOL0172 (c.490C→T; p.R164X) (Figure 2A). In MOL0277, a homozygous intronic change (c.411-8A→G) was the only potentially pathogenic change identified. Sequence of cDNA derived from patients' peripheral blood lymphocyte mRNA demonstrated that this mutation activated a cryptic splice acceptor site giving rise only to an aberrant transcript (Figure 2B). The mutant transcript has seven additional base pairs of sequence added to the beginning of exon 6 and is predicted to introduce a frameshift resulting in premature termination (R137SfsX16). Amplicons from individuals heterozygous and homozygous for the c.766C→T; p.Arg256X mutation were shown to have distinct melting curves by high-resolution melting-curve analysis (HRMCA) when compared to DNA without this mutation (not shown). HRMCA of 138 ethnically matched control individuals confirmed that this mutation was not present in unaffected individuals. The c.490C→T; p.R164X and c.411-8A→G mutations were excluded by direct sequencing in 105 and 160 ethnically matched control individuals, respectively. Two of the human mutations are nonsense changes and the remaining two appear to lead to nonsense changes following splicing defects (Figure 3), strongly suggesting that ADAM9 is likely to be absent in these patients because of nonsense-mediated decay. In order to elucidate the pathogenic mechanism, we therefore investigated previously generated mice that are null for the Adam9 gene and show no major morphological, histopathological, or behavioral abnormalities during development or early adult life.9 We performed ERGs to assess the electrical response of the retina to light in these mice. The rod photoreceptor response of 12-month-old Adam9−/− mice, as measured by the dark-adapted a-wave,10 showed a saturated response of approximately 50% the amplitude of wild-type mice (Figures 4A and 4C, Table 1). Twenty-month-old Adam9−/− mice had saturated a-wave responses approximately 30% the amplitude of the age-matched wild-type (Figures 4B and 4C, Table 1), suggesting a progressive retinal degeneration. Rod b-waves, reflecting the depolarizing response of rod bipolar cells, were less severely but significantly reduced in Adam9−/− mice (Figure 4, Table 1). Although reductions of cone-driven b-wave responses were not statistically significant in 12-month-old mice, probably because of the low proportion of cone photoreceptors in the mouse retina, 20-month-old mice had proportionally greater reductions compared to age-matched wild-types, with statistically significant Student's t test p values (Figure 4C, Table 1). These data suggest a progressive degeneration affecting both rods and cones in Adam9−/− mice. Histological analysis of retinas from 12-month-old Adam9−/− mice showed an abnormal gap between the POS and RPE (Figure 5B). Electron microscopy revealed extended malformed, vesiculated RPE apical processes (Figures 5E and 5F) and disrupted contact with the POS. However, photoreceptors and other neuronal layers appeared structurally normal at this age. Analysis of 20-month-old Adam9−/− mice provided evidence for further degeneration. In addition to the POS-RPE interface abnormalities observed at 12 months, these mice had disorganized POS and a thinning outer nuclear layer (ONL) (Figure 5D), macrophages within the gap between the POS and the RPE (Figure 5L), and unusual infoldings of the basal membrane of the RPE (Figure 5J). In some slides, material could also be seen deposited between the RPE and Bruch's membrane (Figure 5K). These histological findings reveal a progressive degeneration consistent with ERG analyses and implicate the POS-RPE junction as the site at which the pathology first manifests. A defect in the extracellular matrix (ECM) between the POS and the RPE may be responsible for the initial defects in photoreceptor signaling detected by ERGs, in a similar manner to that which has been suggested by analysis of Slc16a8−/− mice.11 It is intriguing to speculate that the basal deposits observed (Figure 5K) may be analogous to the drusen deposits observed in human retinal degenerations, such as CRD and age-related macular degeneration (AMD). It is also interesting to note that macrophages have been implicated in the pathology of AMD. We performed immunofluorescence on mouse retinas to establish Adam9 expression in the eye. Although we observed the brightest Adam9 staining at the apical surface of the RPE (Figure S1), the site of observed pathology in mice, staining of some sections from Adam9−/− mice indicated cross-reactivity at the same site. These data should therefore be interpreted with caution. ADAM9 is a widely expressed and particularly polyvalent member of the multifunctional ADAM family of proteins. It has been implicated in cell-matrix interactions,12 ECM remodeling,13 alpha-secretase activity for amyloid precursor protein (APP),14 HB-EGF shedding,15 and the pathology of cancer16–18 and Alzheimer disease,14 but until now a physiological role remained elusive. It has been suggested previously that absence of an ortholog in Drosophila melanogaster and Caenorhabditis elegans may indicate that ADAM9 functions in cells or organs that are more highly evolved in vertebrates,9 and our data support the idea that ADAM9 fulfills a specific role in the vertebrate retina. Whereas dysregulation of members of the ADAM family has been implicated in the pathogenesis of diseases such as Alzheimer, cancer, rheumatoid arthritis, and asthma (reviewed in 19), and ADAM9 has been shown to be downregulated in cataracts,20 to the best of our knowledge no other germinal mutation in an ADAM has been shown to be the direct cause of disease. Our findings could suggest a defect in adhesion at the POS-RPE interface in the absence of Adam9. Indeed, Adam9 has been shown to function as an adhesion molecule by binding to αvβ5 integrin.21 αvβ5 integrin, the only integrin localized to the apical surface of the RPE,22,23 is required for retinal adhesion24 and phagocytosis of POS.23 In addition, integrin β5−/− mice have age-related vision loss.25 Adam9 at the POS-RPE junction could therefore interact with αvβ5 integrin and may mediate adhesion of POS to the RPE and efficient uptake of shed outer segments. However, ERGs in the Adam9−/− mice appear less severely disturbed than those of β5−/− mice, whereas β5−/− mice lack the morphological abnormalities observed at the RPE-POS junction in Adam9−/− mice. This suggests that Adam9 has an additional role in the retina independent of αvβ5 integrin, possibly in the remodeling of the ECM between the RPE and POS or in the shedding of factors essential for the maintenance of the ECM. Interestingly, genes adjacent to ADAM9 on chromosome 8 (Figure 1C) display a degree of paralogy with the locus on chromosome 10 implicated in AMD,26,27 the functional variant of which is still debated.28–32 The TACC2 (MIM ∗605302), PLEKHA1 (MIM ∗607772), and HTRA1 (MIM ∗602194) genes at the AMD-associated locus on chromosome 10 have paralogs in the form of the TACC1 (MIM ∗605301), PLEKHA2 (MIM ∗607773), and HTRA4 (MIM ∗610700) genes adjacent to ADAM9 at the CORD9 locus on chromosome 8. However, there is no ADAM family member at the AMD locus on chromosome 10. Nevertheless, the fact that these genes lie in the same orientation relative to each other at each locus and that ADAM9 is the next-but-one gene in the same orientation raises an intriguing if speculative possibility that a shared regulatory element for these loci may influence the transcription of ADAM933. Several components of the ECM have been implicated in AMD or AMD-related disorders.31,34–37 Mice with a homozygous mutation in one of these, TIMP3 (MIM ∗188826), encoding an inhibitor of metalloproteases, appear to show disturbances of the apical processes of the RPE in addition to basal infoldings, similar to the changes observed in Adam9−/− mice.38 Although ADAM9 is thought not to be inhibited by TIMP3,39 our data suggest that it may be worthwhile to re-evaluate the possibility of an interaction between these molecules. Furthermore, drusen deposits from cases of AMD have been shown to contain amyloid beta40 and some Adam9−/− mice appear to have drusen-like deposits, so it is tempting to consider that loss of ADAM9, a protease with alpha-secretase activity potentially contributing to the nonamyloidogenic pathway of APP processing, could result in an increase in amyloid beta production. Further analysis of basal deposits in the Adam9−/− retina will be required to test this theory. In summary, we have demonstrated a pathology localized to the POS-RPE junction and leading to retinal degeneration in Adam9−/− mice and shown that ADAM9 mutations cause retinal degeneration in human patients. The milder phenotype of Adam9−/− mice is likely to represent the early stages of the human disease because of a combination of shorter life span, the progressive nature of CORD, and the fact that mice lack a macula, instead showing uniform photoreceptor density. Indeed, the comparatively mild mouse phenotype suggests that the most important function of ADAM9 may be in areas of high photoreceptor density or associated with cones. Whereas several mouse models have exhibited varying forms of retinal degeneration wherein the photoreceptors are not the initial site of pathology, to the best of our knowledge the Adam9−/− phenotype is unique and no human disease has been previously linked to such a phenotype. Our data therefore uncover a physiological role for ADAM9, reveal what we believe may be a novel causative pathway for human retinal degeneration, and highlight a potentially overlooked pathological feature of retinal degenerations, including CRD and AMD. Finally, the observation that photoreceptors appear to be intact in the early stages of the disease also suggests that ADAM9 may be a valid target for gene therapy.

Document structure show

Title	Loss of the Metalloprotease ADAM9 Leads to Cone-Rod Dystrophy in Humans and Retinal Degeneration in Mice
Abstract	Cone-rod dystrophy (CRD) is an inherited progressive retinal dystrophy affecting the function of cone and rod photoreceptors. By autozygosity mapping, we identified null mutations in the ADAM metallopeptidase domain 9 (ADAM9) gene in four consanguineous families with recessively inherited early-onset CRD. We also found reduced photoreceptor responses in Adam9 knockout mice, previously reported to be asymptomatic. In 12-month-old knockout mice, photoreceptors appear normal, but the apical processes of the retinal pigment epithelium (RPE) cells are disorganized and contact between photoreceptor outer segments (POSs) and the RPE apical surface is compromised. In 20-month-old mice, there is clear evidence of progressive retinal degeneration with disorganized POS and thinning of the outer nuclear layer (ONL) in addition to the anomaly at the POS-RPE junction. RPE basal deposits and macrophages were also apparent in older mice. These findings therefore not only identify ADAM9 as a CRD gene but also identify a form of pathology wherein retinal disease first manifests at the POS-RPE junction.
Body	Main Text Cone-rod dystrophy (CRD [MIM #120970]) is a group of genetically and phenotypically heterogenous retinal disorders usually manifesting in childhood or early adulthood. CRD is characterized by predominant or equal loss of cone compared to rod photoreceptors, reduced visual acuity, color-vision abnormalities, photophobia, and visual-field loss. To date, 11 genes and a further six loci have been associated with CRD, which is most commonly inherited in an autosomal-dominant manner (RetNet). So far, only ABCA41–3 (MIM ∗601691) and RPGRIP14 (MIM +605446) mutations have been shown to cause nonsyndromic autosomal-recessive CRD, with two other published recessive loci.5,6 Only RPGR (MIM ∗312610) mutations have been associated with X-linked CRD.7,8 The CRD locus CORD9 on chromosome 8p11 was first identified in a consanguineous Brazilian family with childhood-onset visual-acuity impairment leading to major loss of central and peripheral vision.5 Haplotype analysis revealed a 12 Mb region with two putative homozygous segments (5 and Figure 1A). To further refine the locus, we used autozygosity mapping, genotyping over 200 microsatellite markers and single-nucleotide polymorphisms (SNPs) within the published locus in two affected individuals (Table S1, available online). Known microsatellite markers and SNPs were selected from the UCSC genome browser or the International HapMap project. Where possible, SNPs with relatively high levels of heterozygosity were chosen. Microsatellites were genotyped on an ABI PRISM 377 DNA Sequencer and analyzed with Genscan 2.0.2 and Geno Typer 1.1.1 software (Applied Biosciences). SNPs were analyzed by direct sequencing. The individuals genotyped were from different sibships and are indicated by arrows in Figure 2. These data provided support for a 2.95 Mb homozygous segment between rs10955025 and rs725401 containing 34 genes (Figures 1B and 1C). Candidate genes were chosen on the basis of known expression in the vertebrate retina or eye, homology or functional similarity to known retinal degeneration genes, published studies indicating potential retinal function, and published interactions with proteins thought to be important for retinal function. We amplified genomic DNA by PCR and sequenced ten genes within this region in affected individuals (Figure 1). Sequencing revealed a homozygous point mutation in the ADAM9 gene (MIM ∗602713), altering the first base of intron 11 (c.1130+1G→A) and abolishing the splice-site (Figure 2A). This mutation was excluded in 190 ethnically matched control individuals by restriction digest with BspHI. Further autozygosity mapping with 10k and 250k Affymetrix SNP arrays and microsatellite markers identified three additional CORD9-linked families of Pakistani (MEP49), Tunisian Jewish (MOL0172), and Arab Muslim (MOL0277) origin. Each was consanguineous and showed a recessive inheritance pattern. Affected individuals in these families reported poor visual acuity in the first decade of life, but nystagmus and photophobia were not noted. Outer retinal atrophy was observed in the macula. Most patients had discrete white patches in the posterior pole and around the optic disc with a pigmentary retinopathy, anterior to the equator. The midperipheral retina showed minimal changes on clinical examination of young patients. In older patients, peripheral pigmentary changes could be observed in some cases. As previously published,5 electroretinograms (ERGs) showed a similar degree of rod and cone involvement. The study of human subjects was performed after all individuals provided informed consent. Approval was obtained from the institutional review boards of the participating centers. Direct sequencing of ADAM9 in MEP49 revealed a homozygous point mutation in exon 9, creating a premature stop codon (c.766C→T; p.R256X) (Figure 2A). A second homozygous stop codon was identified in MOL0172 (c.490C→T; p.R164X) (Figure 2A). In MOL0277, a homozygous intronic change (c.411-8A→G) was the only potentially pathogenic change identified. Sequence of cDNA derived from patients' peripheral blood lymphocyte mRNA demonstrated that this mutation activated a cryptic splice acceptor site giving rise only to an aberrant transcript (Figure 2B). The mutant transcript has seven additional base pairs of sequence added to the beginning of exon 6 and is predicted to introduce a frameshift resulting in premature termination (R137SfsX16). Amplicons from individuals heterozygous and homozygous for the c.766C→T; p.Arg256X mutation were shown to have distinct melting curves by high-resolution melting-curve analysis (HRMCA) when compared to DNA without this mutation (not shown). HRMCA of 138 ethnically matched control individuals confirmed that this mutation was not present in unaffected individuals. The c.490C→T; p.R164X and c.411-8A→G mutations were excluded by direct sequencing in 105 and 160 ethnically matched control individuals, respectively. Two of the human mutations are nonsense changes and the remaining two appear to lead to nonsense changes following splicing defects (Figure 3), strongly suggesting that ADAM9 is likely to be absent in these patients because of nonsense-mediated decay. In order to elucidate the pathogenic mechanism, we therefore investigated previously generated mice that are null for the Adam9 gene and show no major morphological, histopathological, or behavioral abnormalities during development or early adult life.9 We performed ERGs to assess the electrical response of the retina to light in these mice. The rod photoreceptor response of 12-month-old Adam9−/− mice, as measured by the dark-adapted a-wave,10 showed a saturated response of approximately 50% the amplitude of wild-type mice (Figures 4A and 4C, Table 1). Twenty-month-old Adam9−/− mice had saturated a-wave responses approximately 30% the amplitude of the age-matched wild-type (Figures 4B and 4C, Table 1), suggesting a progressive retinal degeneration. Rod b-waves, reflecting the depolarizing response of rod bipolar cells, were less severely but significantly reduced in Adam9−/− mice (Figure 4, Table 1). Although reductions of cone-driven b-wave responses were not statistically significant in 12-month-old mice, probably because of the low proportion of cone photoreceptors in the mouse retina, 20-month-old mice had proportionally greater reductions compared to age-matched wild-types, with statistically significant Student's t test p values (Figure 4C, Table 1). These data suggest a progressive degeneration affecting both rods and cones in Adam9−/− mice. Histological analysis of retinas from 12-month-old Adam9−/− mice showed an abnormal gap between the POS and RPE (Figure 5B). Electron microscopy revealed extended malformed, vesiculated RPE apical processes (Figures 5E and 5F) and disrupted contact with the POS. However, photoreceptors and other neuronal layers appeared structurally normal at this age. Analysis of 20-month-old Adam9−/− mice provided evidence for further degeneration. In addition to the POS-RPE interface abnormalities observed at 12 months, these mice had disorganized POS and a thinning outer nuclear layer (ONL) (Figure 5D), macrophages within the gap between the POS and the RPE (Figure 5L), and unusual infoldings of the basal membrane of the RPE (Figure 5J). In some slides, material could also be seen deposited between the RPE and Bruch's membrane (Figure 5K). These histological findings reveal a progressive degeneration consistent with ERG analyses and implicate the POS-RPE junction as the site at which the pathology first manifests. A defect in the extracellular matrix (ECM) between the POS and the RPE may be responsible for the initial defects in photoreceptor signaling detected by ERGs, in a similar manner to that which has been suggested by analysis of Slc16a8−/− mice.11 It is intriguing to speculate that the basal deposits observed (Figure 5K) may be analogous to the drusen deposits observed in human retinal degenerations, such as CRD and age-related macular degeneration (AMD). It is also interesting to note that macrophages have been implicated in the pathology of AMD. We performed immunofluorescence on mouse retinas to establish Adam9 expression in the eye. Although we observed the brightest Adam9 staining at the apical surface of the RPE (Figure S1), the site of observed pathology in mice, staining of some sections from Adam9−/− mice indicated cross-reactivity at the same site. These data should therefore be interpreted with caution. ADAM9 is a widely expressed and particularly polyvalent member of the multifunctional ADAM family of proteins. It has been implicated in cell-matrix interactions,12 ECM remodeling,13 alpha-secretase activity for amyloid precursor protein (APP),14 HB-EGF shedding,15 and the pathology of cancer16–18 and Alzheimer disease,14 but until now a physiological role remained elusive. It has been suggested previously that absence of an ortholog in Drosophila melanogaster and Caenorhabditis elegans may indicate that ADAM9 functions in cells or organs that are more highly evolved in vertebrates,9 and our data support the idea that ADAM9 fulfills a specific role in the vertebrate retina. Whereas dysregulation of members of the ADAM family has been implicated in the pathogenesis of diseases such as Alzheimer, cancer, rheumatoid arthritis, and asthma (reviewed in 19), and ADAM9 has been shown to be downregulated in cataracts,20 to the best of our knowledge no other germinal mutation in an ADAM has been shown to be the direct cause of disease. Our findings could suggest a defect in adhesion at the POS-RPE interface in the absence of Adam9. Indeed, Adam9 has been shown to function as an adhesion molecule by binding to αvβ5 integrin.21 αvβ5 integrin, the only integrin localized to the apical surface of the RPE,22,23 is required for retinal adhesion24 and phagocytosis of POS.23 In addition, integrin β5−/− mice have age-related vision loss.25 Adam9 at the POS-RPE junction could therefore interact with αvβ5 integrin and may mediate adhesion of POS to the RPE and efficient uptake of shed outer segments. However, ERGs in the Adam9−/− mice appear less severely disturbed than those of β5−/− mice, whereas β5−/− mice lack the morphological abnormalities observed at the RPE-POS junction in Adam9−/− mice. This suggests that Adam9 has an additional role in the retina independent of αvβ5 integrin, possibly in the remodeling of the ECM between the RPE and POS or in the shedding of factors essential for the maintenance of the ECM. Interestingly, genes adjacent to ADAM9 on chromosome 8 (Figure 1C) display a degree of paralogy with the locus on chromosome 10 implicated in AMD,26,27 the functional variant of which is still debated.28–32 The TACC2 (MIM ∗605302), PLEKHA1 (MIM ∗607772), and HTRA1 (MIM ∗602194) genes at the AMD-associated locus on chromosome 10 have paralogs in the form of the TACC1 (MIM ∗605301), PLEKHA2 (MIM ∗607773), and HTRA4 (MIM ∗610700) genes adjacent to ADAM9 at the CORD9 locus on chromosome 8. However, there is no ADAM family member at the AMD locus on chromosome 10. Nevertheless, the fact that these genes lie in the same orientation relative to each other at each locus and that ADAM9 is the next-but-one gene in the same orientation raises an intriguing if speculative possibility that a shared regulatory element for these loci may influence the transcription of ADAM933. Several components of the ECM have been implicated in AMD or AMD-related disorders.31,34–37 Mice with a homozygous mutation in one of these, TIMP3 (MIM ∗188826), encoding an inhibitor of metalloproteases, appear to show disturbances of the apical processes of the RPE in addition to basal infoldings, similar to the changes observed in Adam9−/− mice.38 Although ADAM9 is thought not to be inhibited by TIMP3,39 our data suggest that it may be worthwhile to re-evaluate the possibility of an interaction between these molecules. Furthermore, drusen deposits from cases of AMD have been shown to contain amyloid beta40 and some Adam9−/− mice appear to have drusen-like deposits, so it is tempting to consider that loss of ADAM9, a protease with alpha-secretase activity potentially contributing to the nonamyloidogenic pathway of APP processing, could result in an increase in amyloid beta production. Further analysis of basal deposits in the Adam9−/− retina will be required to test this theory. In summary, we have demonstrated a pathology localized to the POS-RPE junction and leading to retinal degeneration in Adam9−/− mice and shown that ADAM9 mutations cause retinal degeneration in human patients. The milder phenotype of Adam9−/− mice is likely to represent the early stages of the human disease because of a combination of shorter life span, the progressive nature of CORD, and the fact that mice lack a macula, instead showing uniform photoreceptor density. Indeed, the comparatively mild mouse phenotype suggests that the most important function of ADAM9 may be in areas of high photoreceptor density or associated with cones. Whereas several mouse models have exhibited varying forms of retinal degeneration wherein the photoreceptors are not the initial site of pathology, to the best of our knowledge the Adam9−/− phenotype is unique and no human disease has been previously linked to such a phenotype. Our data therefore uncover a physiological role for ADAM9, reveal what we believe may be a novel causative pathway for human retinal degeneration, and highlight a potentially overlooked pathological feature of retinal degenerations, including CRD and AMD. Finally, the observation that photoreceptors appear to be intact in the early stages of the disease also suggests that ADAM9 may be a valid target for gene therapy.
Section	Main Text Cone-rod dystrophy (CRD [MIM #120970]) is a group of genetically and phenotypically heterogenous retinal disorders usually manifesting in childhood or early adulthood. CRD is characterized by predominant or equal loss of cone compared to rod photoreceptors, reduced visual acuity, color-vision abnormalities, photophobia, and visual-field loss. To date, 11 genes and a further six loci have been associated with CRD, which is most commonly inherited in an autosomal-dominant manner (RetNet). So far, only ABCA41–3 (MIM ∗601691) and RPGRIP14 (MIM +605446) mutations have been shown to cause nonsyndromic autosomal-recessive CRD, with two other published recessive loci.5,6 Only RPGR (MIM ∗312610) mutations have been associated with X-linked CRD.7,8 The CRD locus CORD9 on chromosome 8p11 was first identified in a consanguineous Brazilian family with childhood-onset visual-acuity impairment leading to major loss of central and peripheral vision.5 Haplotype analysis revealed a 12 Mb region with two putative homozygous segments (5 and Figure 1A). To further refine the locus, we used autozygosity mapping, genotyping over 200 microsatellite markers and single-nucleotide polymorphisms (SNPs) within the published locus in two affected individuals (Table S1, available online). Known microsatellite markers and SNPs were selected from the UCSC genome browser or the International HapMap project. Where possible, SNPs with relatively high levels of heterozygosity were chosen. Microsatellites were genotyped on an ABI PRISM 377 DNA Sequencer and analyzed with Genscan 2.0.2 and Geno Typer 1.1.1 software (Applied Biosciences). SNPs were analyzed by direct sequencing. The individuals genotyped were from different sibships and are indicated by arrows in Figure 2. These data provided support for a 2.95 Mb homozygous segment between rs10955025 and rs725401 containing 34 genes (Figures 1B and 1C). Candidate genes were chosen on the basis of known expression in the vertebrate retina or eye, homology or functional similarity to known retinal degeneration genes, published studies indicating potential retinal function, and published interactions with proteins thought to be important for retinal function. We amplified genomic DNA by PCR and sequenced ten genes within this region in affected individuals (Figure 1). Sequencing revealed a homozygous point mutation in the ADAM9 gene (MIM ∗602713), altering the first base of intron 11 (c.1130+1G→A) and abolishing the splice-site (Figure 2A). This mutation was excluded in 190 ethnically matched control individuals by restriction digest with BspHI. Further autozygosity mapping with 10k and 250k Affymetrix SNP arrays and microsatellite markers identified three additional CORD9-linked families of Pakistani (MEP49), Tunisian Jewish (MOL0172), and Arab Muslim (MOL0277) origin. Each was consanguineous and showed a recessive inheritance pattern. Affected individuals in these families reported poor visual acuity in the first decade of life, but nystagmus and photophobia were not noted. Outer retinal atrophy was observed in the macula. Most patients had discrete white patches in the posterior pole and around the optic disc with a pigmentary retinopathy, anterior to the equator. The midperipheral retina showed minimal changes on clinical examination of young patients. In older patients, peripheral pigmentary changes could be observed in some cases. As previously published,5 electroretinograms (ERGs) showed a similar degree of rod and cone involvement. The study of human subjects was performed after all individuals provided informed consent. Approval was obtained from the institutional review boards of the participating centers. Direct sequencing of ADAM9 in MEP49 revealed a homozygous point mutation in exon 9, creating a premature stop codon (c.766C→T; p.R256X) (Figure 2A). A second homozygous stop codon was identified in MOL0172 (c.490C→T; p.R164X) (Figure 2A). In MOL0277, a homozygous intronic change (c.411-8A→G) was the only potentially pathogenic change identified. Sequence of cDNA derived from patients' peripheral blood lymphocyte mRNA demonstrated that this mutation activated a cryptic splice acceptor site giving rise only to an aberrant transcript (Figure 2B). The mutant transcript has seven additional base pairs of sequence added to the beginning of exon 6 and is predicted to introduce a frameshift resulting in premature termination (R137SfsX16). Amplicons from individuals heterozygous and homozygous for the c.766C→T; p.Arg256X mutation were shown to have distinct melting curves by high-resolution melting-curve analysis (HRMCA) when compared to DNA without this mutation (not shown). HRMCA of 138 ethnically matched control individuals confirmed that this mutation was not present in unaffected individuals. The c.490C→T; p.R164X and c.411-8A→G mutations were excluded by direct sequencing in 105 and 160 ethnically matched control individuals, respectively. Two of the human mutations are nonsense changes and the remaining two appear to lead to nonsense changes following splicing defects (Figure 3), strongly suggesting that ADAM9 is likely to be absent in these patients because of nonsense-mediated decay. In order to elucidate the pathogenic mechanism, we therefore investigated previously generated mice that are null for the Adam9 gene and show no major morphological, histopathological, or behavioral abnormalities during development or early adult life.9 We performed ERGs to assess the electrical response of the retina to light in these mice. The rod photoreceptor response of 12-month-old Adam9−/− mice, as measured by the dark-adapted a-wave,10 showed a saturated response of approximately 50% the amplitude of wild-type mice (Figures 4A and 4C, Table 1). Twenty-month-old Adam9−/− mice had saturated a-wave responses approximately 30% the amplitude of the age-matched wild-type (Figures 4B and 4C, Table 1), suggesting a progressive retinal degeneration. Rod b-waves, reflecting the depolarizing response of rod bipolar cells, were less severely but significantly reduced in Adam9−/− mice (Figure 4, Table 1). Although reductions of cone-driven b-wave responses were not statistically significant in 12-month-old mice, probably because of the low proportion of cone photoreceptors in the mouse retina, 20-month-old mice had proportionally greater reductions compared to age-matched wild-types, with statistically significant Student's t test p values (Figure 4C, Table 1). These data suggest a progressive degeneration affecting both rods and cones in Adam9−/− mice. Histological analysis of retinas from 12-month-old Adam9−/− mice showed an abnormal gap between the POS and RPE (Figure 5B). Electron microscopy revealed extended malformed, vesiculated RPE apical processes (Figures 5E and 5F) and disrupted contact with the POS. However, photoreceptors and other neuronal layers appeared structurally normal at this age. Analysis of 20-month-old Adam9−/− mice provided evidence for further degeneration. In addition to the POS-RPE interface abnormalities observed at 12 months, these mice had disorganized POS and a thinning outer nuclear layer (ONL) (Figure 5D), macrophages within the gap between the POS and the RPE (Figure 5L), and unusual infoldings of the basal membrane of the RPE (Figure 5J). In some slides, material could also be seen deposited between the RPE and Bruch's membrane (Figure 5K). These histological findings reveal a progressive degeneration consistent with ERG analyses and implicate the POS-RPE junction as the site at which the pathology first manifests. A defect in the extracellular matrix (ECM) between the POS and the RPE may be responsible for the initial defects in photoreceptor signaling detected by ERGs, in a similar manner to that which has been suggested by analysis of Slc16a8−/− mice.11 It is intriguing to speculate that the basal deposits observed (Figure 5K) may be analogous to the drusen deposits observed in human retinal degenerations, such as CRD and age-related macular degeneration (AMD). It is also interesting to note that macrophages have been implicated in the pathology of AMD. We performed immunofluorescence on mouse retinas to establish Adam9 expression in the eye. Although we observed the brightest Adam9 staining at the apical surface of the RPE (Figure S1), the site of observed pathology in mice, staining of some sections from Adam9−/− mice indicated cross-reactivity at the same site. These data should therefore be interpreted with caution. ADAM9 is a widely expressed and particularly polyvalent member of the multifunctional ADAM family of proteins. It has been implicated in cell-matrix interactions,12 ECM remodeling,13 alpha-secretase activity for amyloid precursor protein (APP),14 HB-EGF shedding,15 and the pathology of cancer16–18 and Alzheimer disease,14 but until now a physiological role remained elusive. It has been suggested previously that absence of an ortholog in Drosophila melanogaster and Caenorhabditis elegans may indicate that ADAM9 functions in cells or organs that are more highly evolved in vertebrates,9 and our data support the idea that ADAM9 fulfills a specific role in the vertebrate retina. Whereas dysregulation of members of the ADAM family has been implicated in the pathogenesis of diseases such as Alzheimer, cancer, rheumatoid arthritis, and asthma (reviewed in 19), and ADAM9 has been shown to be downregulated in cataracts,20 to the best of our knowledge no other germinal mutation in an ADAM has been shown to be the direct cause of disease. Our findings could suggest a defect in adhesion at the POS-RPE interface in the absence of Adam9. Indeed, Adam9 has been shown to function as an adhesion molecule by binding to αvβ5 integrin.21 αvβ5 integrin, the only integrin localized to the apical surface of the RPE,22,23 is required for retinal adhesion24 and phagocytosis of POS.23 In addition, integrin β5−/− mice have age-related vision loss.25 Adam9 at the POS-RPE junction could therefore interact with αvβ5 integrin and may mediate adhesion of POS to the RPE and efficient uptake of shed outer segments. However, ERGs in the Adam9−/− mice appear less severely disturbed than those of β5−/− mice, whereas β5−/− mice lack the morphological abnormalities observed at the RPE-POS junction in Adam9−/− mice. This suggests that Adam9 has an additional role in the retina independent of αvβ5 integrin, possibly in the remodeling of the ECM between the RPE and POS or in the shedding of factors essential for the maintenance of the ECM. Interestingly, genes adjacent to ADAM9 on chromosome 8 (Figure 1C) display a degree of paralogy with the locus on chromosome 10 implicated in AMD,26,27 the functional variant of which is still debated.28–32 The TACC2 (MIM ∗605302), PLEKHA1 (MIM ∗607772), and HTRA1 (MIM ∗602194) genes at the AMD-associated locus on chromosome 10 have paralogs in the form of the TACC1 (MIM ∗605301), PLEKHA2 (MIM ∗607773), and HTRA4 (MIM ∗610700) genes adjacent to ADAM9 at the CORD9 locus on chromosome 8. However, there is no ADAM family member at the AMD locus on chromosome 10. Nevertheless, the fact that these genes lie in the same orientation relative to each other at each locus and that ADAM9 is the next-but-one gene in the same orientation raises an intriguing if speculative possibility that a shared regulatory element for these loci may influence the transcription of ADAM933. Several components of the ECM have been implicated in AMD or AMD-related disorders.31,34–37 Mice with a homozygous mutation in one of these, TIMP3 (MIM ∗188826), encoding an inhibitor of metalloproteases, appear to show disturbances of the apical processes of the RPE in addition to basal infoldings, similar to the changes observed in Adam9−/− mice.38 Although ADAM9 is thought not to be inhibited by TIMP3,39 our data suggest that it may be worthwhile to re-evaluate the possibility of an interaction between these molecules. Furthermore, drusen deposits from cases of AMD have been shown to contain amyloid beta40 and some Adam9−/− mice appear to have drusen-like deposits, so it is tempting to consider that loss of ADAM9, a protease with alpha-secretase activity potentially contributing to the nonamyloidogenic pathway of APP processing, could result in an increase in amyloid beta production. Further analysis of basal deposits in the Adam9−/− retina will be required to test this theory. In summary, we have demonstrated a pathology localized to the POS-RPE junction and leading to retinal degeneration in Adam9−/− mice and shown that ADAM9 mutations cause retinal degeneration in human patients. The milder phenotype of Adam9−/− mice is likely to represent the early stages of the human disease because of a combination of shorter life span, the progressive nature of CORD, and the fact that mice lack a macula, instead showing uniform photoreceptor density. Indeed, the comparatively mild mouse phenotype suggests that the most important function of ADAM9 may be in areas of high photoreceptor density or associated with cones. Whereas several mouse models have exhibited varying forms of retinal degeneration wherein the photoreceptors are not the initial site of pathology, to the best of our knowledge the Adam9−/− phenotype is unique and no human disease has been previously linked to such a phenotype. Our data therefore uncover a physiological role for ADAM9, reveal what we believe may be a novel causative pathway for human retinal degeneration, and highlight a potentially overlooked pathological feature of retinal degenerations, including CRD and AMD. Finally, the observation that photoreceptors appear to be intact in the early stages of the disease also suggests that ADAM9 may be a valid target for gene therapy.
Title	Main Text

Annnotations TAB TSV DIC JSON TextAE

Denotations: 5
Blocks: 0
Relations: 0

PMC:2681008 / 1161-1168 JSONTXT

Document structure show

Annnotations TAB TSV DIC JSON TextAE

PMC:2681008 / 1161-1168 JSON TXT